Wednesday, 28 February 2018
Print
| DAY 1 | Main Exhibition Hall | DAY 1 |
| DAY 1 | Main Exhibition Hall | DAY 1 |
| 8:00 | 8:00: | |
| 8:05: | 8:05: | |
| 8:10: | 8:10: | |
| 8:15: | 8:15: | |
| 8:20: | 8:20: | |
| 8:25: | 8:25: | |
| 8:30: | 8:30: | |
| 8:35: | 8:35: | |
| 8:40: | 8:40: | |
| 8:45: | Registration & Coffee | 8:45: |
| 8:50: | 8:50: | |
| 8:55: | 8:55: | |
| 9:00 | 9:00: | |
| 9:05: | 9:05: | |
| 9:10: | 9:10: | |
| 9:15: | 9:15: | |
| 9:20: | 9:20: | |
| 9:25: | 9:25: | |
| 9:30: | 9:30: | |
| 9:35: | 9:35: | |
| 9:40: | 9:40: | |
| 9:45: | Welcome & Introduction to the Plenary Keynote | 9:45: |
| 9:50: | Future trends in lab automation - an applied research perspective by nICLAS Innovation Centre
09:50 (45 mins) Mario Bott, Fraunhofer nICLAS |
9:50: |
| 9:55: | 9:55: | |
| 10:00 | 10:00 | |
| 10:05 | 10:05 | |
| 10:10 | 10:10 | |
| 10:15 | 10:15 | |
| 10:20 | 10:20 | |
| 10:25 | 10:25 | |
| 10:30 | 10:30 | |
| 10:35 | Modernising Pharma R&D:what, why and how 10:35 (30 mins) Laura Williams, GlaxoSmithKline |
10:35 |
| 10:40 | 10:40 | |
| 10:45 | 10:45 | |
| 10:50 | 10:50 | |
| 10:55 | 10:55 | |
| 11:00 | 11:00 | |
| 11:05 | Coffee Break | 11:05 |
| 11:10 | 11:10 | |
| 11:15 | 11:15 | |
| 11:20 | 11:20 | |
| 11:25 | 11:25 | |
| 11:30 | 11:30 | |
| 11:35 | 11:35 | |
| 11:40 | 11:40 | |
| 11:45 | 11:45 | |
| 11:50 | Industry drivers for the smart lab 11:50 (30 mins) Paul Kendall, Festo Some economic aspects of robotics and automation for the laboratory 12:20 (15 mins) Patrick Courtney, tec-connection |
11:50 |
| 11:55 | 11:55 | |
| 12:00 | 12:00 | |
| 12:05 | 12:05 | |
| 12:10 | 12:10 | |
| 12:15 | 12:15 | |
| 12:20 | 12:20 | |
| 12:25 | 12:25 | |
| 12:30 | 12:30 | |
| 12:35 | Miltenyi Biotec Fully automated isolation of cell subsets StraightFrom® blood products. Presented by - Lotta Raety Isolating leukocytes from blood products such as buffy coat, LRSC or whole blood is a key step in ma...[More] |
12:35 |
| 12:40 | 12:40 | |
| 12:45 | Lunch | 12:45 |
| 12:50 | 12:50 | |
| 12:55 | 12:55 | |
| 1:00 | 1:00: | |
| 1:05: | 1:05: | |
| 1:10: | 1:10: | |
| 1:15: | 1:15: | |
| 1:20: | 1:20: | |
| 1:25: | 1:25: | |
| 1:30: | 1:30: | |
| 1:35: | 1:35: | |
| 1:40: | 1:40: | |
| 1:45: | 1:45: | |
| 1:50: | 1:50: | |
| 1:55: | 1:55: | |
| 2:00 | 2:00: | |
| 2:05: | 2:05: | |
| 2:10: | 2:10: | |
| 2:15: | The application of Cloud Technologies to Automated Robotic Scheduling Applications 14:15 (30 mins) Colin Thurston, Brooks Life Sciences Medicines Discovery Catapult – Co-Creating drug discovery technologies and platforms 14:45 (15 mins) Peter Simpson, Medicines Discovery Catapult |
2:15: |
| 2:20: | 2:20: | |
| 2:25: | 2:25: | |
| 2:30: | 2:30: | |
| 2:35: | 2:35: | |
| 2:40: | 2:40: | |
| 2:45: | 2:45: | |
| 2:50: | 2:50: | |
| 2:55: | 2:55: | |
| 3:00 | Coffee Break | 3:00: |
| 3:05: | 3:05: | |
| 3:10: | 3:10: | |
| 3:15: | 3:15: | |
| 3:20: | 3:20: | |
| 3:25: | 3:25: | |
| 3:30: | 3:30: | |
| 3:35: | 3:35: | |
| 3:40: | 3:40: | |
| 3:45: | Accelerating drug discovery through a fully automated Design-Make-Test-Analyse workflow 15:45 (30 mins) Michael Kossenjans, AstraZeneca |
3:45: |
| 3:50: | 3:50: | |
| 3:55: | 3:55: | |
| 4:00 | 4:00: | |
| 4:05: | 4:05: | |
| 4:10: | 4:10: | |
| 4:15: | Vendor networking reception with food and drinks 16:15 (105 mins) |
4:15: |
| 4:20: | 4:20: | |
| 4:25: | 4:25: | |
| 4:30: | 4:30: | |
| 4:35: | 4:35: | |
| 4:40: | 4:40: | |
| 4:45: | 4:45: | |
| 4:50: | 4:50: | |
| 4:55: | 4:55: | |
| 5:00 | 5:00: | |
| 5:05: | 5:05: | |
| 5:10: | 5:10: | |
| 5:15: | 5:15: | |
| 5:20: | 5:20: | |
| 5:25: | 5:25: | |
| 5:30: | 5:30: | |
| 5:35: | 5:35: | |
| 5:40: | 5:40: | |
| 5:45: | 5:45: | |
| 5:50: | 5:50: | |
| 5:55: | 5:55: | |
| 6:00 | 6:00: |